Calliditas Therapeutics AB (publ) (NASDAQ:CALT – Get Free Report) had its target price decreased by analysts at Guggenheim from $21.00 to $18.00 in a report released on Friday, FlyOnTheWall reports. Guggenheim's price objective would suggest a potential upside of 8.17% from the company's current price. Separately, HC Wainwright initiated coverage on shares of Calliditas Therapeutics […] The post Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Price Target Cut to $18.00 first appeared on Daily Political .

https://www.dailypolitical.com/2023/08/18/calliditas-therapeutics-ab-publ-nasdaqcalt-price-target-cut-to-18-00.html

#dailypolitical